Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
.jpg)
Antibody & Protein Engineering
Q&A with Silvia Crescioli, Business Intelligence Creator, The Antibody Society
We catch up with Silvia Crescioli from The Antibody Society to unpack the latest trends and technologies fuelling progress in antibody therapeutic development.
Antibody / Protein Production & Purification
Fast-Track Formulation with Biologics Screening in a Snap
On-demand webinar presented by Ross Walton, Senior Application Scientist for Analytics at Unchained Labs
Stem Cell Therapy
Q&A with Terri Gaskell, Chief Technology Officer, Rinri Therapeutics
We catch up with Terri Gaskell from Rinri Tx to discuss how they are reversing hearing loss using stem cell based regenerative medicine.
NextGen Therapeutics
Historic Islet Cell Transplant Offers Hope for a Permanent Cure for Type 1 Diabetes
A study led by Professor Deng Hongkui at Peking University successfully treated a type 1 diabetes patient by transplanting insulin-producing islet cells derived from the patient's reprogrammed stem cells.
NextGen Therapeutics
Lonza and Vertex Pen Long Term Supply Deal for CASGEVY
Lonza will provide scientific, regulatory and manufacturing capabilities to Vertex, as well as use of their global manufacturing network.
NextGen Therapeutics
Tackling Tumours from Within: Tumour Reprogramming Offers Hope in Cancer Immunotherapy
A novel gene therapy developed by Asgard Therapeutics and Lund University reprograms tumour cells into cancer-fighting immune cells.
Microbiome
New Research into Newborn Gut Microbiome Identifies Three “Pioneer Bacteria” for Babies’ Microbiota Development
The researchers analysed high-resolution genomic information from over 1,200 babies and identified three pioneer bacteria that drive the development of the gut microbiota.
Drug Discovery & Development
Insilico Medicine and Inimmune Pen Collaboration for AI-Powered Immunotherapy Discovery
The two biotechs are working together to overcome specific hurdles in the immunotherapy drug discovery process.
Stem Cell Therapy
Kyoto University Hospital Explores the Potential of Treating Type 1 Diabetes Using Induced Pluripotent Stem Cells
Kyoto University Hospital aims to develop a treatment for severe Type 1 diabetes using induced pluripotent stem cells (iPSCs) reprogrammed to function as pancreatic islet cells.
Regulatory
Regeneron’s Bispecific Gets EU Approval After FDA Rejection
The approval means that the bispecific antibody odronextamab can be used to treat adult patients with relapsed or refractory follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) in the EU.
Antibody & Protein Engineering
Absci to Collaborate with the Memorial Sloan Kettering Cancer Center to Develop Biologics using AI
The two organisations will work side by side on up to six programmes which will develop new cancer drug candidates using AI.
Antibody-based Therapies
MSD to Acquire Bispecific Antibody From Curon in Bid to Diversify Portfolio
The novel investigational clinical stage bispecific antibody targets CD3xCD19 to engage T cells with malignant B cells.